Two-pronged attack on DNA repair could kill drug-resistant cancers
Launching a two-pronged attack on cancer's ability to safeguard its DNA could offer an effective new way of treating the disease, a new study reports.
Mar 12, 2020
0
335
Launching a two-pronged attack on cancer's ability to safeguard its DNA could offer an effective new way of treating the disease, a new study reports.
Mar 12, 2020
0
335
In a new peer-reviewed publication, University of Illinois at Chicago researchers describe how the body's response to inflammation, which helps to fight many kinds of infections, also can counterproductively suppress much-needed ...
Mar 11, 2020
0
154
Researchers at Princeton University have identified a set of human proteins that the hepatitis B virus (HBV) uses to establish itself permanently inside liver cells. The study, published in the journal Nature Microbiology, ...
Mar 9, 2020
0
83
A new 'toolkit' to repair damaged DNA that can lead to ageing, cancer and Motor Neurone Disease (MND) has been discovered by scientists at the Universities of Sheffield and Oxford.
Mar 9, 2020
0
559
A study at The University of Texas MD Anderson Cancer Center discovered a novel therapeutic vulnerability for patients who have tumors caused by a genetic misfire in the DNA mismatch repair (MMR) pathway, a system for repairing ...
Feb 27, 2020
0
2
A study led by The University of Texas MD Anderson Cancer Center furthered understanding about mitochondria, the cell components known as the "powerhouse of the cell." Knowing more about the genome is crucial given that mitochondria ...
Feb 6, 2020
0
312
A new study has uncovered a previously unknown role for the enzyme EXD2, identifying it as a potential drug target for cancer therapy.
Dec 19, 2019
0
2
A pioneering precision medicine already licensed for breast and ovarian cancer can also slow or stop tumour growth in some men with advanced prostate cancer, a new clinical trial shows.
Dec 3, 2019
0
2
Some men with advanced prostate cancer who have exhausted all other treatment options could live for two years or more on immunotherapy, a major clinical trial has shown.
Nov 27, 2019
0
5
Researchers at the University of Alberta have discovered a new class of drugs with the potential to make cancer treatment safer and more effective by preventing cancer cells from repairing themselves.
Nov 20, 2019
0
13